Giuseppe Giannini

21PUBLICATIONS
81CO-AUTHORS
Gene and molecular therapyGene expression (incl. microarray and other genome-wide approaches)Molecular targetsBiologically active moleculesMolecular medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|May 12, 2026
Brain-Targeted Delivery of Phenformin Using Phospholipid and Non-Phospholipid Vesicles for SHH Medulloblastoma.

|Apr 20, 2026
Distinct cellular effects of myotonic dystrophy type 2 repeat-associated non-AUG tetrapeptides.

|Feb 26, 2026
Partial truncation of the C-terminal domain of PTCH1 in cancer promotes tumourigenesis by non-canonical activation of a GLI-PI3K loop.

Begoña Caballero-Ruiz, Rosa Bordone, Sonia Coni

|Feb 25, 2026
4-(5-Chloro-3-(3,4,5-trimethoxybenzoyl)-1H-indol-1-yl)benzenesulfonamide: A Novel Polypharmacology Agent to Target Carbonic Anhydrase IX and XII With Improved Selectivity, Wnt/β-Catenin Signaling Pathway, and P-Glycoprotein.

Michela Puxeddu, Rosa Bordone, Claudia Colla

|Dec 18, 2025
Opposite effects of spermidine and GC7 in cell culture are dictated by distinct molecular targets.

Tomoaki Tahara, Rosa Bordone, Antonio Francesco Campese

|Dec 18, 2024
SMURF1 and SMURF2 directly target GLI1 for ubiquitination and proteasome-dependent degradation.

Fabio Bordin, Gloria Terriaca, Adriano Apostolico

Pageof 4

Frequent Collaborators

5 joint publications

Laura Di Magno

4 joint publications

Enrico De Smaele

3 joint publications

Natalia A Riobo-Del Galdo

3 joint publications

Giuseppe Giannini